Member Info for Cloudy390

Perhaps someone has got wind of Brazil working, I’m sure foralumab response is quite quick and then antibodies build up over a period of time.

That 50 million dollar investment may just turn into 50 billion.

Because I can say I have the solution to all your problems and I will shortly be proving this. And I have now started to prove this, RESULT.

Because Nasdaq goes on results, starting Covid trial is a result!

Painting by numbers, join the dots or what Pmsl.

I think they just don’t believe it.or they do and want to bury it. For some reason .Who knows!
Or probably they just want your shares whoever or whatever your game plan ??????

Excellent interview with Proactive Investor, tell it like it is, monumental. Ain’t no stopping us now. The reason Novimmune stop trials was toxicity through IV,now new patented method of admin, proven non toxic phase 1 safety trials . Anytime now. Soooon.

It’s an expediated suck it and see trial.

These trials are not secret, any positive response ,I imagine would be leaked. I’m expecting foralumab to work quite quickly after administering, news will out as always. GLA

Hope this hits the news channels now, as it should, enormous game changer.

Yes , with that in mind I think that no news is good news as it means all is going as planned, if things have changed some what they would have RNS.

Do they actually have to say they have started as that’s what they said they would be doing and also for ages they have said in the end blurb on the rns’s that they won’t be updating the market on things they said would be happening. Correct me if I’m wrong.

We won’t know til we float that Stem boat on the open sea . goodnight all .

Possibly get hammered, RNS!

The board of Tils have said all what I said.

Personally I would say Least 2.50. Which would give a mc of half bill , as it has been tried and tested
By experts and just needs the rubber stamp , so to speak.

Joey your not listening, the market had no value for stem in Tils, the whole point of demerger, so no reduction in Tils share price on demerger, especially if RNS is released on news we all know is imminent . Stem will find its own value on float , but I personally would start very high as no money is to be raised yet.

Oh 2p submitted to court , leaves us Tils with 1p. But hey doesn’t mean a thing Share Price has no relation nominal share value , especially when we have so many goodies.

Why would demerging stem affect share price when the actual spending on stem was about 3mill and no one even knew about stems potential until recently, which is not reflected in Tils share price hence the reason for demerger, which begs the question of nda’s with Tils drugs not stem so it seems to me that Tils will be sold and stem has been demergered so as to not include it in Tils which it had little value in. It’s not rocket science GLA

Tils nominal share price 3p,on the share certs,stem will only reduce nominal share value by maybe .003p. So should not matter at all, but this is aim so who knows. Capital reduction is only on the nominal share value not the share price, correct me if I’m wrong